William Kearney
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
William Kearney has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Connor Ross
Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA; and
4 shared publications - Joan W. Miller
Department of Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA
4 shared publications - Joshua B. Gilbert
Center for School Behavioral Health, Massachusetts General Hospital
3 shared publications - Tobias Elze
Massachusetts Eye and Ear Infirmary, Harvard University, Boston, MA; and
3 shared publications Alexander Roland Miranda
2 shared publicationsAlice C. Lorch
Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts USA
2 shared publications
Latest Publications
- 9 October 2026
- Published by Wolters Kluwer Health in Cornea
Surgical Management Patterns and Outcomes in Recurrent Corneal Erosion: An IRIS Registry Study
Purpose: Surgical management of recurrent corneal erosion (RCE) lacks large-scale evidence, and national patterns of care and procedural outcomes remain incompletely defined. We characterized national practice patterns, repeat surgery rates, and risk factors for surgical failure using the American Academy of Ophthalmology IRIS Registry. Methods: Retrospective cohort study of patients with RCE between 2016 and 2025. Multilevel logistic regression and Cox proportional hazards modeling were used to evaluate odds of surgical intervention and hazard of repeat surgery after phototherapeutic keratectomy (PTK), epithelial debridement, and anterior stromal puncture (ASP). Results: Among 187,112 eyes with RCE, 12,956 (6.9%) underwent surgery: 5590 (43.0%) PTK, 5038 (39.0%) epithelial debridement, and 2328 (18.0%) ASP. Mean follow-up was 2.23 years. Two-year cumulative incidence of repeat surgery was 12% for PTK, 17% for epithelial debridement, and 29% for ASP. ASP carried a 2.5-fold higher hazard of repeat surgery versus PTK (HR 2.50, 95% CI 2.22–2.78, P < 0.001) and 64% higher versus epithelial debridement (HR 1.64, 95% CI 1.47–1.85, P < 0.001). Among eyes with RCE, concomitant epithelial basement membrane dystrophy was the ocular comorbidity most strongly associated with undergoing surgery (OR 2.57, 95% CI 2.35–2.81, P < 0.001). RCE etiology, including epithelial basement membrane dystrophy (HR 0.90), other dystrophies (HR 1.02), and prior trauma (HR 1.07), was not associated with surgical failure. Conclusions: Despite continued use as a first-line therapy, ASP carries substantially higher repeat intervention risk compared with laser and manual corneal surface procedures. Initial procedure choice, rather than underlying indication or comorbidity, was the primary predictor of surgical failure, underscoring the importance of surgical selection for recurrent corneal erosion.
- 9 October 2026
- Published by Wolters Kluwer Health in Cornea
Surgical Management Patterns and Outcomes in Recurrent Corneal Erosion: An IRIS Registry Study
Purpose: Surgical management of recurrent corneal erosion (RCE) lacks large-scale evidence, and national patterns of care and procedural outcomes remain incompletely defined. We characterized national practice patterns, repeat surgery rates, and risk factors for surgical failure using the American Academy of Ophthalmology IRIS Registry. Methods: Retrospective cohort study of patients with RCE between 2016 and 2025. Multilevel logistic regression and Cox proportional hazards modeling were used to evaluate odds of surgical intervention and hazard of repeat surgery after phototherapeutic keratectomy (PTK), epithelial debridement, and anterior stromal puncture (ASP). Results: Among 187,112 eyes with RCE, 12,956 (6.9%) underwent surgery: 5590 (43.0%) PTK, 5038 (39.0%) epithelial debridement, and 2328 (18.0%) ASP. Mean follow-up was 2.23 years. Two-year cumulative incidence of repeat surgery was 12% for PTK, 17% for epithelial debridement, and 29% for ASP. ASP carried a 2.5-fold higher hazard of repeat surgery versus PTK (HR 2.50, 95% CI 2.22–2.78, P < 0.001) and 64% higher versus epithelial debridement (HR 1.64, 95% CI 1.47–1.85, P < 0.001). Among eyes with RCE, concomitant epithelial basement membrane dystrophy was the ocular comorbidity most strongly associated with undergoing surgery (OR 2.57, 95% CI 2.35–2.81, P < 0.001). RCE etiology, including epithelial basement membrane dystrophy (HR 0.90), other dystrophies (HR 1.02), and prior trauma (HR 1.07), was not associated with surgical failure. Conclusions: Despite continued use as a first-line therapy, ASP carries substantially higher repeat intervention risk compared with laser and manual corneal surface procedures. Initial procedure choice, rather than underlying indication or comorbidity, was the primary predictor of surgical failure, underscoring the importance of surgical selection for recurrent corneal erosion.
- 25 February 2026
- Published by Elsevier in Ophthalmology Glaucoma
- Vol. 9 (5) , 484-493
Corneal Endothelial Keratoplasty After Glaucoma Treatment: An American Academy of Ophthalmology IRIS® Registry Analysis
- 25 February 2026
- Published by Elsevier in Ophthalmology Glaucoma
- Vol. 9 (5) , 484-493
Corneal Endothelial Keratoplasty After Glaucoma Treatment: An American Academy of Ophthalmology IRIS® Registry Analysis
- Open Access
- 19 November 2025
- Published by Elsevier in Ophthalmology Retina
- Vol. 10 (4) , 411-419
Epidemiology, Clinical Features, and Visual Outcomes After Intraocular Foreign Body Removal
- 19 November 2025
- Published by Elsevier in Ophthalmology Retina
- Vol. 10 (4) , 411-419
Open AccessEpidemiology, Clinical Features, and Visual Outcomes After Intraocular Foreign Body Removal
- Open Access
Patient and Practice Level Visual Acuity Prior to Cataract Surgery: An IRIS ® Registry (Intelligent Research in Sight) Analysis
Purpose: To examine the influence of patient demographic characteristics and ophthalmic practice composition on access to cataract surgery in the United States as measured by preoperative best-corrected visual acuity (BCVA). Patient and methods: This retrospective cohort study analyzed data from the IRIS ® Registry (Intelligent Research in Sight) for patients age > 50 who had at least one BCVA measurement in the six months preceding cataract surgery performed between January 1, 2016, and December 31, 2020. We used a mixed-effects model to estimate the relationship between individual-level demographic factors and practice-level composition factors and preoperative BCVA. Results: 2,387,045 individuals met inclusion criteria. The mean BCVA prior to surgery was 0.23 (SD: 0.32) logMAR. The worst pre-operative BCVA was observed in patients with Hispanic race and ethnicity while White patients had the best [0.34 (SD: 0.43), 0.21(SD: 0.30); pP < .001) while patients at practices with higher percentages of actively smoking patients showed worse BCVA (b=-0.016 per 10 percentage points active smoking patients, P < .001). There was no compositional effect of insurance status. Conclusions and Relevance: Overall differences exist with regard to the visual acuity at which cataract surgery is initiated at both the level of the individual patient and the composition of practice in which they are treated. Plain Language Summary: Demographic disparities and geographic variation in access to cataract surgery in the United States have been previously described in large national studies of insurance data. Smaller studies of single institutions expanded upon these studies by showing differences in preoperative visual acuity- an important measure of access to cataract surgery- based on factors such as race and insurance status but were limited by the size and scope of their study patients. The IRIS ® Registry (Intelligent Research in Sight) is the nation’s first comprehensive ophthalmic clinical registry with data from both individual patients as well as ophthalmic group practices. Using data from this registry, we show differences in preoperative visual acuity prior to cataract surgery at both the level of the patient and the practice in which they are treated.
Open AccessPatient and Practice Level Visual Acuity Prior to Cataract Surgery: An IRIS ® Registry (Intelligent Research in Sight) Analysis
Purpose: To examine the influence of patient demographic characteristics and ophthalmic practice composition on access to cataract surgery in the United States as measured by preoperative best-corrected visual acuity (BCVA). Patient and methods: This retrospective cohort study analyzed data from the IRIS ® Registry (Intelligent Research in Sight) for patients age > 50 who had at least one BCVA measurement in the six months preceding cataract surgery performed between January 1, 2016, and December 31, 2020. We used a mixed-effects model to estimate the relationship between individual-level demographic factors and practice-level composition factors and preoperative BCVA. Results: 2,387,045 individuals met inclusion criteria. The mean BCVA prior to surgery was 0.23 (SD: 0.32) logMAR. The worst pre-operative BCVA was observed in patients with Hispanic race and ethnicity while White patients had the best [0.34 (SD: 0.43), 0.21(SD: 0.30); pP < .001) while patients at practices with higher percentages of actively smoking patients showed worse BCVA (b=-0.016 per 10 percentage points active smoking patients, P < .001). There was no compositional effect of insurance status. Conclusions and Relevance: Overall differences exist with regard to the visual acuity at which cataract surgery is initiated at both the level of the individual patient and the composition of practice in which they are treated. Plain Language Summary: Demographic disparities and geographic variation in access to cataract surgery in the United States have been previously described in large national studies of insurance data. Smaller studies of single institutions expanded upon these studies by showing differences in preoperative visual acuity- an important measure of access to cataract surgery- based on factors such as race and insurance status but were limited by the size and scope of their study patients. The IRIS ® Registry (Intelligent Research in Sight) is the nation’s first comprehensive ophthalmic clinical registry with data from both individual patients as well as ophthalmic group practices. Using data from this registry, we show differences in preoperative visual acuity prior to cataract surgery at both the level of the patient and the practice in which they are treated.